KORU Medical Systems (KRMD) Liabilities and Shareholders Equity (2011 - 2026)
KORU Medical Systems (KRMD) recorded quarterly Liabilities and Shareholders Equity of $28.6 million in Q1 2026, up 1.39% quarter-over-quarter from $28.2 million in Q4 2025, and up 5.05% on a YoY basis from $27.2 million in Q1 2025.
KORU Medical Systems (KRMD) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
KORU Medical Systems' Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $28.6 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 5.05% year-over-year to $28.6 million; the TTM figure through Mar 2026 stood at $109.4 million (changed 0.26% YoY), while the FY2025 annual figure was $28.2 million, up 3.61% from the prior year.
- Liabilities and Shareholders Equity was $28.6 million for Q1 2026 at KORU Medical Systems, up from $28.2 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $43.4 million in Q1 2022 to a low of $25.5 million in Q2 2025.
- Historically, Liabilities and Shareholders Equity has averaged $32.6 million across 5 years, with a median of $28.5 million in 2023.
- The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity slumped 32.77% in 2023, then grew 5.05% in 2026.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $42.3 million in 2022, then plunged by 32.77% to $28.5 million in 2023, then declined by 4.37% to $27.2 million in 2024, then rose by 3.61% to $28.2 million in 2025, then climbed by 1.39% to $28.6 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $28.6 million (Q1 2026), $28.2 million (Q4 2025), and $27.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | KORU Medical Systems | 183.37 Mn | 174.57 Mn | 7.23 Mn | 28.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.59 Mn |
| Dec 31, 2025 | 28.20 Mn |
| Sep 30, 2025 | 27.10 Mn |
| Jun 30, 2025 | 25.52 Mn |
| Mar 31, 2025 | 27.22 Mn |
| Dec 31, 2024 | 27.22 Mn |
| Sep 30, 2024 | 27.39 Mn |
| Jun 30, 2024 | 27.30 Mn |
| Mar 31, 2024 | 27.50 Mn |
| Dec 31, 2023 | 28.46 Mn |
| Sep 30, 2023 | 35.35 Mn |
| Jun 30, 2023 | 36.00 Mn |
| Mar 31, 2023 | 38.25 Mn |
| Dec 31, 2022 | 42.33 Mn |
| Sep 30, 2022 | 42.67 Mn |
| Jun 30, 2022 | 42.46 Mn |
| Mar 31, 2022 | 43.43 Mn |
| Dec 31, 2021 | 41.29 Mn |
| Sep 30, 2021 | 41.36 Mn |
| Jun 30, 2021 | 40.60 Mn |